Anabolic X-Factor (Molecular Nutrition)

User rating
3.5
out of 5
31 user reviews

0 forum posts
Anabolic X-Factor (Molecular Nutrition)

Clinically tested at Baylor University for safety and effectiveness, Anabolic X-Factor™ is the world’s first patented hypertrophic catalyst. X-Factor drastically amplifies the body’s sensitivity and responsiveness to resistance training, resulting in faster and more profound increases in muscle size, strength, even the rate of lipolysis (fat loss). University trials confirm remarkable increases in muscle strength, power, and endurance, adding X-Factor to the elite ranks of select few clinically proven ergogenic agents.

If you click on a hyperlinked ingredient, you will get to the ingredient search page with that ingredient selected.

Supplement Facts
Serving Size 1 Softgel
Servings Per Container 60
Amount per Serving % Daily Value
Arachidonic Acid 250 mg
† Daily Value not established.



X-Factor Oil (A Blend Of Arachidonic Acid, Palmitic Acid, Stearic Acid, Linoleic Acid, Y-Linoleic Acid, Dihomo-Y-Linoleic Acid, Myristic Acid, Arachidic Acid, Behenic Acid, Lignoceric Acid, And Other Fatty Acids), Gelatin, Glycerin, Water, Caramel Color, And Carob.

Sold Under U.S. Patent # 6,841,573.


As a dietary supplement, take 1 softgel 3-4 times daily for 50 days (2 bottles are required for a full cycle). Take with meals. Do not exceed recommended dosage. Take 50 days off before repeating. To maximize benefits, avoid regular use of anti-inflammatory products while taking X-Factor. Note that due to the nature of this product, it may take 14-21 days before significant results are noticed.


Do not take this product if you are pregnant or nursing, or have any history of diabetes, asthma, high blood pressure, high cholesterol, arthritis, heart disease, stroke, colitis, irritable bowel syndrome, cancer, prostate enlargement or any inflammatory disease. Consult with your physician before use if you are taking any medication(s), or suffer from any health condition.


 
 
 
comments powered by Disqus